Clorox’s (CLX) Hold Rating Reiterated at Jefferies Group
Several other brokerages also recently commented on CLX. Zacks Investment Research downgraded shares of Clorox from a hold rating to a sell rating in a research note on Wednesday, October 4th. Wells Fargo & Co boosted their target price on shares of Clorox from $130.00 to $146.00 and gave the company a market perform rating in a research note on Thursday, January 4th. BMO Capital Markets reiterated a buy rating and set a $150.00 price target on shares of Clorox in a research report on Thursday, October 5th. Bank of America upgraded shares of Clorox from an underperform rating to a neutral rating and set a $155.00 price target on the stock in a research report on Thursday, January 4th. Finally, Consumer Edge raised Clorox from a neutral rating to an outperform rating in a report on Friday, November 10th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the stock. Clorox has a consensus rating of Hold and a consensus price target of $134.19.
Clorox (CLX) opened at $140.96 on Thursday. Clorox has a 52-week low of $119.57 and a 52-week high of $150.40. The company has a market cap of $18,391.80, a P/E ratio of 25.96, a PEG ratio of 3.73 and a beta of 0.42. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77.
The company also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is currently 61.88%.
In other news, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares in the company, valued at approximately $4,742,260.67. The disclosure for this sale can be found here. Corporate insiders own 1.00% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Sun Life Financial INC increased its position in Clorox by 10,344.4% during the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after buying an additional 931 shares during the period. Acrospire Investment Management LLC bought a new position in Clorox during the 2nd quarter worth $133,000. Phocas Financial Corp. bought a new position in shares of Clorox in the second quarter worth $167,000. Salem Investment Counselors Inc. increased its position in shares of Clorox by 2.5% in the second quarter. Salem Investment Counselors Inc. now owns 1,256 shares of the company’s stock worth $167,000 after purchasing an additional 31 shares during the period. Finally, Jacobi Capital Management LLC increased its position in shares of Clorox by 0.3% in the second quarter. Jacobi Capital Management LLC now owns 1,286 shares of the company’s stock worth $172,000 after purchasing an additional 4 shares during the period. Hedge funds and other institutional investors own 73.20% of the company’s stock.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.